{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:20:24Z","timestamp":1791559224260,"version":"4.3.4"},"reference-count":24,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2025,9,23]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background\/aims<\/jats:title>\n                    <jats:p>To find biomarkers on OCT-angiography (OCT-A) that indicate a higher risk of recurrence in neovascular age-related macular degeneration (nAMD) patients before anti-vascular endothelial growth factor (anti-VEGF) therapy termination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective, observational study. Stable, inactive nAMD patients who had been treated with a treat-and-extend regimen and met the predefined exit criteria were included. The macular neovascularisation (MNV) lesion was imaged on OCT-A. Lesion area, vessel density (VD), fractal dimension and height of feeder vessel were quantified. Patients with disease recurrence after termination were compared with those who stayed inactive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 819 eyes diagnosed with nAMD and 281 with a 2-year follow-up, 77 (27.4%) reached the exit criteria. Thirty-four eyes of 33 (15 female) patients with reliable OCT-A were further analysed. Mean age was 80.35 (\u00b19.29) years, the number of injections was 16.68 (\u00b18.22). Treatment duration before exit was 36.15 (\u00b116.63) months. After exit, 23 eyes stayed inactive for a follow-up period of 23.00 (\u00b116.18) months, and 11 experienced recurrence after 13.36 (\u00b19.90) months. VD was significantly higher in the recurrent versus inactive group with 0.60 (\u00b10.15) versus 0.47 (\u00b10.11), p=0.015. There was an insignificant tendency for the protective properties of type 1 MNV and a low feeder vessel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>OCT-A is useful in the risk calculation for recurrence in patients who are about to discontinue anti-VEGF treatments in nAMD. Patients with a high VD might need closer follow-ups or continued anti-VEGF treatments even if inactive.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjo-2025-327721","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:10:19Z","timestamp":1760083819000},"page":"440-445","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating the risk of recurrence in neovascular age-related macular degeneration using OCT-angiography at the time of treatment exit"],"prefix":"10.1136","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3670-6983","authenticated-orcid":false,"given":"Damian","family":"Jaggi","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Marugg","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieselotte E","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6227-2242","authenticated-orcid":false,"given":"Marion R","family":"Munk","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"},{"name":"Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3447-2359","authenticated-orcid":false,"given":"Martin S","family":"Zinkernagel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"},{"name":"Bern Photographic Reading Centre, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0536-9870","authenticated-orcid":false,"given":"Florian M","family":"Heussen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"},{"name":"Bern Photographic Reading Centre, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"2026032002151780000_110.4.440.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054481"},{"key":"2026032002151780000_110.4.440.2","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.ophtha.2016.07.012","article-title":"Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration","volume":"123","author":"Essex","year":"2016","journal-title":"Ophthalmology"},{"key":"2026032002151780000_110.4.440.3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.oret.2017.07.009","article-title":"Recurrence Rate of Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration Managed with a Treat-Extend-Stop Protocol","volume":"2","author":"Adrean","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"2026032002151780000_110.4.440.4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.oret.2021.03.010","article-title":"Recurrent Neovascular Age-Related Macular Degeneration after Discontinuation of Vascular Endothelial Growth Factor Inhibitors Managed in a Treat-and-Extend Regimen","volume":"6","author":"Aslanis","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"2026032002151780000_110.4.440.5","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001923"},{"key":"2026032002151780000_110.4.440.6","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1204026","article-title":"Discontinuation of treatment and retreatment of neovascular age-related macular degeneration in the real-world: Bundang AMD cohort study report 5","volume":"10","author":"Cho","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2026032002151780000_110.4.440.7","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-316514"},{"key":"2026032002151780000_110.4.440.8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.oret.2017.07.010","article-title":"The Impact of the Vitreomacular Interface in Neovascular Age-Related Macular Degeneration in a Treat-and-Extend Regimen with Exit Strategy","volume":"2","author":"Munk","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"2026032002151780000_110.4.440.9","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001628"},{"key":"2026032002151780000_110.4.440.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.11.004"},{"key":"2026032002151780000_110.4.440.11","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2019"},{"key":"2026032002151780000_110.4.440.12","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2089"},{"key":"2026032002151780000_110.4.440.13","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bioeng.6.040803.140100"},{"key":"2026032002151780000_110.4.440.14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.oret.2019.11.018","article-title":"Comparison of Automated versus Manually Modified OCT Angiography En Face Slabs for Detection of Choroidal Neovascularization","volume":"4","author":"Siggel","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"2026032002151780000_110.4.440.15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61551-z","article-title":"Effect of manual OCTA segmentation correction to improve image quality and visibility of choroidal neovascularization in AMD","volume":"14","author":"Deussen","year":"2024","journal-title":"Sci Rep"},{"key":"2026032002151780000_110.4.440.16","doi-asserted-by":"crossref","DOI":"10.1186\/s40942-020-00242-z","article-title":"The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degeneration","volume":"6","author":"Levine","year":"2020","journal-title":"Int J Retina Vitreous"},{"key":"2026032002151780000_110.4.440.17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12051973","article-title":"Comparison of Automated Thresholding Algorithms in Optical Coherence Tomography Angiography Image Analysis","volume":"12","author":"Prangel","year":"2023","journal-title":"J Clin Med"},{"key":"2026032002151780000_110.4.440.18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94333-y","article-title":"The impact of different thresholds on optical coherence tomography angiography images binarization and quantitative metrics","volume":"11","author":"Arrigo","year":"2021","journal-title":"Sci Rep"},{"key":"2026032002151780000_110.4.440.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205513","article-title":"Quantitative optical coherence tomography angiography biomarkers for neovascular age-related macular degeneration in remission","volume":"13","author":"Coscas","year":"2018","journal-title":"PLoS One"},{"key":"2026032002151780000_110.4.440.20","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9479183","article-title":"Application of ImageJ in Optical Coherence Tomography Angiography (OCT-A): A Literature Review","volume":"2023","author":"Rahimi","year":"2023","journal-title":"J Ophthalmol"},{"key":"2026032002151780000_110.4.440.21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41433-024-03295-8","article-title":"Optical coherence tomography angiography in neovascular age-related macular degeneration: comprehensive review of advancements and future perspective","volume":"39","author":"Tillmann","year":"2025","journal-title":"Eye (Lond)"},{"key":"2026032002151780000_110.4.440.22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75530-x","article-title":"Baseline optical coherence tomography angiography biomarkers predict visual outcomes in treatment-na\u00efve neovascular age-related macular degeneration patients","volume":"14","author":"Faghihi","year":"2024","journal-title":"Sci Rep"},{"key":"2026032002151780000_110.4.440.23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12886-022-02749-5","article-title":"Biomarkers of macular neovascularisation activity using optical coherence tomography angiography in treated stable neovascular age related macular degeneration","volume":"23","author":"Hanumunthadu","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"2026032002151780000_110.4.440.24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/ceo.14444","article-title":"Reactivation of stable neovascular age\u2010related macular degeneration following treat\u2010and\u2010extend regimen discontinuation","volume":"53","author":"Artiaga","year":"2025","journal-title":"Clinical Exper Ophthalmology"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2025-327721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:15:54Z","timestamp":1773998154000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2025-327721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,3,20]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bjo-2025-327721"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2025-327721","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}